In addition, SLC25A22 promoted the development and metastasis of colon cancer in mice, and colorectal cancer patients overexpressing SLC25A22 have a shorter survival time than patients with low SLC25A22 expression. This evidence concerns the gene SLC25A22 and malignant colon neoplasm.